Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ries RE"" wg kryterium: Autor


Tytuł:
A longitudinal single-cell atlas of treatment response in pediatric AML.
Autorzy:
Lambo S; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Trinh DL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jin D; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Setiadi A; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, Division of Hematopathology, Children's and Women's Health Centre of British Columbia, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Ng M; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada; Department of Medical Genetics and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
Leblanc VG; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Loken MR; Hematologics, Incorporated, Seattle, WA, USA.
Brodersen LE; Hematologics, Incorporated, Seattle, WA, USA.
Dai F; Hematologics, Incorporated, Seattle, WA, USA.
Pardo LM; Hematologics, Incorporated, Seattle, WA, USA.
Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Vercauteren SM; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, Division of Hematopathology, Children's and Women's Health Centre of British Columbia, Vancouver, BC, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada; Department of Medical Genetics and Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2023 Dec 11; Vol. 41 (12), pp. 2117-2135.e12. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Humans ; Child ; Prognosis ; Recurrence
Czasopismo naukowe
Tytuł:
Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
Autorzy:
Hoff FW; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Qiu Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Brown BD; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gerbing RB; COG Statistics and Data Center, Monrovia, California, USA.
Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA.
Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA.
Alonzo TA; COG Statistics and Data Center, Monrovia, California, USA.; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jenkins GN; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA.
Horton TM; Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas, USA.
Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Proteomics. Clinical applications [Proteomics Clin Appl] 2023 Nov; Vol. 17 (6), pp. e2200109. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Cycle Proteins*/genetics
Cell Cycle Proteins*/metabolism
Endoplasmic Reticulum Chaperone BiP*
Child ; Humans ; Bortezomib/pharmacology ; Bortezomib/therapeutic use ; Bortezomib/metabolism ; Protein Serine-Threonine Kinases/metabolism ; Unfolded Protein Response ; Valosin Containing Protein/genetics ; Valosin Containing Protein/metabolism
Czasopismo naukowe
Tytuł:
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.
Autorzy:
Bertrums EJM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology/Hematology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands; Oncode Institute, Utrecht. .
Smith JL; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
Harmon L; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI.
Ries RE; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
Wang YJ; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA; Children's Oncology Group, Monrovia, CA.
Alonzo TA; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA; Children's Oncology Group, Monrovia, CA.
Menssen AJ; Hematologics, Inc, Seattle, WA.
Chisholm KM; Department of Laboratories, Seattle Children's Hospital, Seattle, WA.
Leonti AR; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
Tarlock K; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA.
Ostronoff F; Intermountain Blood and Marrow Transplant and Acute Leukemia Program, Intermountain Healthcare, Salt Lake City, UT.
Pogosova-Agadjanyan EL; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
Kaspers GJL; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, The Netherlands; Dutch Childhood Oncology Group.
Hasle H; Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.
Dworzak M; Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria; St. Anna Kinderspital, Department of Pediatrics, Medical University of Vienna, Vienna.
Walter C; Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen.
Muhlegger N; Children's Cancer Research Institute, Medical University of Vienna, Vienna.
Morerio C; Laboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, Genoa.
Pardo L; Hematologics, Inc, Seattle, WA.
Hirsch B; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Raimondi S; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Cooper TM; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA.
Aplenc R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA.
Gamis AS; Division of Hematology/Oncology, Children's Mercy Kansas City, Kansas City, MO.
Kolb EA; Nemours Alfred I. duPont Hospital for Children, Wilmington, DE.
Farrar JE; Arkansas Children's Research Institute and Department of Pediatrics, Hematology/Oncology Section, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR.
Stirewalt D; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
Ma X; Computational Biology Department, St. Jude Children's Research Hospital, Memphis, TN.
Shaw TI; Computational Biology Department, St. Jude Children's Research Hospital, Memphis, TN.
Furlan SN; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
Brodersen LE; Hematologics, Inc, Seattle, WA.
Loken MR; Hematologics, Inc, Seattle, WA.
Van den Heuvel-Eibrink MM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Utrecht University, Utrecht.
Zwaan CM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology/Hematology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands; Dutch Childhood Oncology Group.
Triche TJ; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA; Department of Pediatrics, Michigan State University College of Human Medicine, Grand Rapids, MI.
Goemans BF; Princess Maxima Center for Pediatric Oncology, Utrecht.
Meshinchi S; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA; Children's Oncology Group, Monrovia, CA, USA; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA. .
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2023 Aug 01; Vol. 108 (8), pp. 2044-2058. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Child ; Young Adult ; Humans ; Mutation ; Nuclear Pore Complex Proteins/genetics ; Gene Expression Profiling ; Retinoblastoma-Binding Protein 2/genetics
Czasopismo naukowe
Tytuł:
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Autorzy:
Chisholm KM; Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.
Smith J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Heerema-McKenney AE; Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Choi JK; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Hirsch BA; Division of Laboratory Medicine, University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, USA.
Raimondi SC; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Wang YC; Children's Oncology Group, Monrovia, California, USA.
Dang A; Children's Oncology Group, Monrovia, California, USA.
Alonzo TA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Sung L; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Aplenc R; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Gamis AS; Children's Mercy Hospitals & Clinics, Kansas City, Missouri, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Kahwash SB; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 May; Vol. 70 (5), pp. e30251. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/mortality
Leukemia, Myeloid, Acute*/pathology
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Young Adult ; Cytogenetic Analysis ; Disease-Free Survival ; Down Syndrome/genetics ; Gene Fusion ; Mutation Rate
Czasopismo naukowe
Tytuł:
Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Autorzy:
Liu Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Klein J; Department of Cell and Molecular Biology and Center for Advanced Genome Editing, St. Jude Children's Research Hospital, Memphis, TN, USA.
Bajpai R; Department of Cell and Molecular Biology and Center for Advanced Genome Editing, St. Jude Children's Research Hospital, Memphis, TN, USA.
Dong L; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Tran Q; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Kolekar P; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Huang BJ; Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Tian L; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Mulder HL; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Shaw TI; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Walsh MP; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Song G; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Westover T; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Autry RJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Gout AM; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wheeler DA; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wan S; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wu G; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yang JJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Evans WE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Loh M; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Easton J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Zhang J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Klco JM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. .
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. .
Brown PA; Bristol Myers Squibb, Princeton, NJ, USA. .
Pruett-Miller SM; Department of Cell and Molecular Biology and Center for Advanced Genome Editing, St. Jude Children's Research Hospital, Memphis, TN, USA. .
Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Apr 05; Vol. 14 (1), pp. 1739. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Core Binding Factor Alpha 2 Subunit*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Humans ; Child ; Oncogene Fusion ; Transcriptome ; Causality ; Oncogene Proteins, Fusion/genetics
Czasopismo naukowe
Tytuł:
Functional consequence and therapeutic targeting of cryptic ALK fusions in monosomy 7 acute myeloid leukemia.
Autorzy:
Manselle MK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, University of Washington, Seattle, Washington, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Hylkema T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Leonti A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Kirkey DC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, University of Washington, Seattle, Washington, USA.
Furlan SN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Clinical Research Division, University of Washington, Seattle, Washington, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Apr; Vol. 70 (4), pp. e30180. Date of Electronic Publication: 2023 Jan 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute*/drug therapy
Child ; Humans ; Chromosome Deletion ; Crizotinib/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Receptor Protein-Tyrosine Kinases/genetics ; Receptor Protein-Tyrosine Kinases/therapeutic use
SCR Disease Name:
Chromosome 7, monosomy
Czasopismo naukowe
Tytuł:
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes.
Autorzy:
Bolouri H; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA. .
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA.
Wiedeman AE; Center for Translational Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA.
Hylkema T; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA.
Scheiding S; Center for Translational Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA.
Gersuk VH; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA.
O'Brien K; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA.
Nguyen QA; Center for Systems Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA.
Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA.; Research Scientific Computing, Seattle Children's Research Institute, 818 Stewart Street, Seattle, WA, USA.
Alice Long S; Center for Translational Immunology, Benaroya Research Institute, 1201 9th Ave, Seattle, WA, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Nov 23; Vol. 13 (1), pp. 7186. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Bone Marrow*/metabolism
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Humans ; Child ; Interleukin-6/metabolism ; Signal Transduction/genetics
Czasopismo naukowe
Tytuł:
Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.
Autorzy:
Hoff FW; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Van Dijk AD; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Qiu Y; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Hu CW; Department of Bioengineering, Rice University, Houston, TX, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Ligeralde A; Biophysics, University of California, Berkeley, CA, USA.
Jenkins GN; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Gerbing RB; University of Southern California, Los Angeles, CA, USA.
Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Aplenc R; Division of Pediatric Oncology/Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kolb EA; Nemours Center for Cancer and Blood Disorders, Emory University, Atlanta GA, USA.
Alonzo TA; University of Southern California, Los Angeles, CA, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Qutub AA; Department of Biomedical Engineering, The University of Texas at San Antonio, USA;.
De Bont ESJM; Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Horton TM; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Kornblau SM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2022 Oct 01; Vol. 107 (10), pp. 2329-2343. Date of Electronic Publication: 2022 Oct 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Proteomics*
Bortezomib ; Child ; Humans ; Prognosis ; Protein Array Analysis ; Proteins
Czasopismo naukowe
Tytuł:
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
Autorzy:
Huang BJ; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. .; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. .
Smith JL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Farrar JE; University of Arkansas for Medical Sciences & Arkansas Children's Research Institute, Little Rock, AR, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Umeda M; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ries RE; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Leonti AR; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Crowgey E; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.
Furlan SN; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Tarlock K; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Armendariz M; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Liu Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Shaw TI; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wei L; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Cooper TM; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Gamis AS; Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Aplenc R; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kolb EA; Nemours Center for Cancer and Blood Disorders and Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.
Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ma J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Klco JM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ma X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
Triche T Jr; Van Andel Research Institute, Grand Rapids, MI, USA.
Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Sep 19; Vol. 13 (1), pp. 5487. Date of Electronic Publication: 2022 Sep 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Profiling*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Biomarkers ; Child ; Humans ; Neoplastic Stem Cells ; RNA ; Recurrence
Czasopismo naukowe
Tytuł:
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Autorzy:
Braun TP; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Okhovat M; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Coblentz C; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Carratt SA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Foley A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Schonrock Z; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Curtiss BM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Nevonen K; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Davis B; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Garcia B; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
LaTocha D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Weeder BR; Program in Molecular and Cellular Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Grzadkowski MR; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Estabrook JC; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Manning HG; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Watanabe-Smith K; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Jeng S; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
McWeeney S; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Di Genua C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.
Drissen R; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.
Nerlov C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.; Division of Pediatric Hematology/Oncology, University of Washington, Seattle, WA, 98195, USA.
Carbone L; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 97239, USA.
Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.; Howard Hughes Medical Institute, Portland, OR, USA.
Maxson JE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. .; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Jun 16; Vol. 13 (1), pp. 3471. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Published Erratum
Tytuł:
The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia.
Autorzy:
Noort S; Pediatric Oncology/Hematology, Erasmus MC-Sophia Children Hospital Rotterdam, The Netherlands.
Wander P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Alonzo TA; Children's Oncology Group, Monrovia, California, USA.
Smith J; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Ries RE; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Gerbing RB; Children's Oncology Group, Monrovia, California, USA.
Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Locatelli F; IRCCS Ospedale Bambino Gesú, Sapienza, University of Rome, Rome, Italy.
Reinhardt D; AML-BFM Study Group, Pediatric Hematology and Oncology, Essen, Germany.
Baruchel A; University Hospital Robert Debré and Paris Diderot University, Paris, France.
Stary J; CPH, University Hospital Motol and Charles University, Prague, Czech Republic.
Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Stam RW; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Zwaan MC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Meshinchi S; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, USA.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2021 Feb 01; Vol. 106 (2), pp. 630-634. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Nuclear Pore Complex Proteins*/genetics
Child ; Homeodomain Proteins/genetics ; Humans ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Retinoblastoma-Binding Protein 2 ; Translocation, Genetic
Raport
Tytuł:
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Autorzy:
Braun TP; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Okhovat M; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Coblentz C; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Carratt SA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Foley A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Schonrock Z; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Curtiss BM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Nevonen K; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Davis B; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Garcia B; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
LaTocha D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.
Weeder BR; Program in Molecular and Cellular Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Grzadkowski MR; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Estabrook JC; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Manning HG; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Watanabe-Smith K; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Computational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Jeng S; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Smith JL; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
McWeeney S; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Di Genua C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.
Drissen R; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.
Nerlov C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.; Division of Pediatric Hematology/Oncology, University of Washington, Seattle, WA, 98195, USA.
Carbone L; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 97239, USA.
Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA.; Howard Hughes Medical Institute, Portland, OR, USA.
Maxson JE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. .; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2019 Nov 29; Vol. 10 (1), pp. 5455. Date of Electronic Publication: 2019 Nov 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
CCAAT-Enhancer-Binding Proteins/*genetics
Leukemia, Myeloid, Acute/*genetics
Receptors, Colony-Stimulating Factor/*genetics
Animals ; Cell Differentiation/genetics ; Cell Lineage/genetics ; Humans ; K562 Cells ; Loss of Function Mutation ; Mice ; Mutation
Czasopismo naukowe
Tytuł:
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Autorzy:
Ma X; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Liu Y; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Liu Y; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Alexandrov LB; Department of Cellular and Molecular Medicine and Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA.
Edmonson MN; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Gawad C; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Zhou X; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Li Y; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Rusch MC; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Easton J; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Huether R; Independent Researcher, Chicago, Illinois 60654, USA.
Gonzalez-Pena V; Oncology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Wilkinson MR; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Hermida LC; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Davis S; Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
Sioson E; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Pounds S; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Cao X; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Wang Z; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Chen X; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Dong L; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Diskin SJ; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland 20892, USA.
Guidry Auvil JM; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Meltzer PS; Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
Lau CC; Division of Hematology-Oncology, Connecticut Children's Medical Center, Hartford, Connecticut 06106, USA.; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA.
Perlman EJ; Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois 60208, USA.
Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Hunger SP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Gerhard DS; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Zhang J; Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Pokaż więcej
Źródło:
Nature [Nature] 2018 Mar 15; Vol. 555 (7696), pp. 371-376. Date of Electronic Publication: 2018 Feb 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Profiling*
Gene Expression Regulation, Neoplastic*
Genome, Human/*genetics
Leukemia/*genetics
Mutation/*genetics
Neoplasms/*genetics
Alleles ; Aneuploidy ; Child ; DNA Copy Number Variations ; Exome/genetics ; Humans ; Mutation/radiation effects ; Mutation Rate ; Oncogenes/genetics ; Precision Medicine/trends ; Ultraviolet Rays/adverse effects
Czasopismo naukowe
Tytuł:
Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Alonzo TA; Department of Biostatistics, University of Southern California, Los Angeles, CA, USA.; Children's Oncology Group, Monrovia, CA, USA.
Gudgeon CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Kentsis A; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College of Cornell University, New York, NY, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Raimondi SC; Children's Oncology Group, Monrovia, CA, USA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Hirsch BA; Children's Oncology Group, Monrovia, CA, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN, USA.
Gamis AS; Children's Oncology Group, Monrovia, CA, USA.; Division of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.; Children's Oncology Group, Monrovia, CA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA.
Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. .; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. .; Department of Epidemiology, University of Washington, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2016 Nov 30; Vol. 9 (1), pp. 133. Date of Electronic Publication: 2016 Nov 30.
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł:
High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Alonzo TA; Department of Biostatistics, University of Southern California, Los Angeles, CA, USA.; Children's Oncology Group, Monrovia, CA, USA.
Gudgeon CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Kentsis A; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College of Cornell University, New York, NY, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Raimondi SC; Children's Oncology Group, Monrovia, CA, USA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Hirsch BA; Children's Oncology Group, Monrovia, CA, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN, USA.
Gamis AS; Children's Oncology Group, Monrovia, CA, USA.; Division of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.; Children's Oncology Group, Monrovia, CA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA.
Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. .; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. .; Department of Epidemiology, University of Washington, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2015 Oct 20; Vol. 8, pp. 115. Date of Electronic Publication: 2015 Oct 20.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms:
Aminoglycosides/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Gene Expression Regulation, Leukemic/*drug effects
Leukemia, Myeloid/*drug therapy
Acute Disease ; Adolescent ; Adult ; Aminoglycosides/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Bone Marrow/drug effects ; Bone Marrow/metabolism ; Bone Marrow/pathology ; Child ; Child, Preschool ; Female ; Gemtuzumab ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid/genetics ; Leukemia, Myeloid/metabolism ; MEF2 Transcription Factors/genetics ; MEF2 Transcription Factors/metabolism ; Male ; Multivariate Analysis ; Prognosis ; Regression Analysis ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction ; Risk Factors ; Survival Analysis ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Transcriptome Profiling of Pediatric Core Binding Factor AML.
Autorzy:
Hsu CH; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America.
Nguyen C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America.
Yan C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America.
Ries RE; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Chen QR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America.
Hu Y; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America.
Ostronoff F; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Stirewalt DL; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Komatsoulis G; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America.
Levy S; Hudson Alpha Institute for Biotechnology, Huntsville, AL, United States of America.
Meerzaman D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, 20850, United States of America.
Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Sep 23; Vol. 10 (9), pp. e0138782. Date of Electronic Publication: 2015 Sep 23 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Profiling*
Core Binding Factor alpha Subunits/*metabolism
Leukemia, Myeloid, Acute/*genetics
Acetylation ; Alternative Splicing ; Binding Sites ; Chromosome Inversion ; Chromosomes, Human, Pair 16 ; Chromosomes, Human, Pair 21 ; Chromosomes, Human, Pair 8 ; Core Binding Factor Alpha 2 Subunit/metabolism ; Core Binding Factor beta Subunit/metabolism ; Gene Regulatory Networks ; Homeodomain Proteins/metabolism ; Humans ; Karyotyping ; Leukemia, Myeloid, Acute/pathology ; Myeloid Ecotropic Viral Integration Site 1 Protein ; Neoplasm Proteins/metabolism ; Principal Component Analysis ; Protein Binding ; Sequence Analysis, RNA ; Transcription Factors/metabolism ; Transcriptome ; Translocation, Genetic
Czasopismo naukowe
Tytuł:
Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group.
Autorzy:
Vujkovic M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address: .
Attiyeh EF; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Horn M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Goodman EK; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ding Y; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kavcic M; University Medical Centre, Ljubljana, Slovenia.
Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Hirsch B; University of Minnesota, Minneapolis, MN, USA.
Raimondi S; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Gamis AS; Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Aplenc R; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Cancer genetics [Cancer Genet] 2015 Jul-Aug; Vol. 208 (7-8), pp. 408-13. Date of Electronic Publication: 2015 May 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
DNA Copy Number Variations*
Loss of Heterozygosity*
Genome-Wide Association Study/*methods
Genotyping Techniques/*methods
Leukemia, Myeloid/*genetics
Acute Disease ; Female ; Genotype ; Humans ; Male ; Microarray Analysis/methods ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle, WA , USA.
Ries RE
Gudgeon CJ
Harrington KH
Alonzo TA
Gerbing RB
Raimondi SC
Hirsch BA
Gamis AS
Meshinchi S
Walter RB
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2014 Dec; Vol. 55 (12), pp. 2817-21. Date of Electronic Publication: 2014 Mar 24.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression*
Leukemia, Myeloid, Acute/*genetics
Leukemia, Myeloid, Acute/*mortality
Suppressor of Cytokine Signaling Proteins/*genetics
Adolescent ; Child ; Child, Preschool ; Disease Progression ; Female ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/therapy ; Male ; Neoplasm, Residual ; Pilot Projects ; Prognosis ; RNA, Messenger/genetics ; Recurrence ; Young Adult
Czasopismo naukowe
Tytuł:
Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington; Department of Epidemiology, University of Washington, Seattle, Washington.
Laszlo GS
Alonzo TA
Gerbing RB
Levy S
Fitzgibbon MP
Gudgeon CJ
Ries RE
Harrington KH
Raimondi SC
Hirsch BA
Gamis AS
W McIntosh M
Meshinchi S
Pokaż więcej
Źródło:
American journal of hematology [Am J Hematol] 2013 Aug; Vol. 88 (8), pp. 694-702. Date of Electronic Publication: 2013 Jun 20.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Biomarkers, Tumor*/biosynthesis
Biomarkers, Tumor*/genetics
Integrin alpha5*/biosynthesis
Integrin alpha5*/genetics
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Leukemia, Myeloid, Acute*/mortality
Gene Expression Regulation, Leukemic/*genetics
RNA Splicing/*genetics
Transcriptome/*genetics
Adult ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Risk Factors ; Survival Rate
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies